Painful Eruptions in a Patient With Cholangiocarcinoma Treated With Fibroblast Growth Factor Receptor Inhibitor

被引：0
|
作者：
Wylie, Natasha S. [1 ]
Sokumbi, Olayemi [2 ]
Starr, Jason S. [1 ]
机构：
[1] Mayo Clin, Div Hematol & Med Oncol, 4500 San Pablo Rd, Jacksonville, FL 32224 USA
[2] Mayo Clin, Dept Dermatol, Jacksonville, FL 32224 USA
来源：
JAMA ONCOLOGY | 2021年 / 7卷 / 12期
关键词：
D O I：
10.1001/jamaoncol.2021.5578
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：1891 / 1892
页数：2
相关论文
共 50 条
  • [1] Pemigatinib Fibroblast growth factor receptor inhibitor Treatment of cholangiocarcinoma
    Franco, B.
    Clarke, P.
    Carotenuto, P.
    DRUGS OF THE FUTURE, 2019, 44 (12) : 923 - 932
  • [2] Fibroblast growth factor receptor (FGFR) inhibitor Treatment of intrahepatic cholangiocarcinoma
    Shaib, W. L.
    El-Rayes, B. F.
    DRUGS OF THE FUTURE, 2017, 42 (11) : 677 - 683
  • [3] Antitumor Activity of a Novel Fibroblast Growth Factor Receptor Inhibitor for Intrahepatic Cholangiocarcinoma
    Raggi, Chiara
    Fiaccadori, Karim
    Pastore, Mirella
    Correnti, Margherita
    Piombanti, Benedetta
    Forti, Elisa
    Navari, Nadia
    Abbadessa, Giovanni
    Hall, Terence
    Destro, Annarita
    Di Tommaso, Luca
    Roncalli, Massimo
    Meng, Fanyin
    Glaser, Shannon
    Rovida, Elisabetta
    Peraldo-Neia, Caterina
    Olaizola, Paula
    Banales, Jesus M.
    Gerussi, Alessio
    Elvevi, Alessandra
    Busset, Michele Droz Dit
    Bhoori, Sherrie
    Mazzaferro, Vincenzo
    Alpini, Gianfranco
    Marra, Fabio
    Invernizzi, Pietro
    AMERICAN JOURNAL OF PATHOLOGY, 2019, 189 (10): : 2090 - 2101
  • [4] Role of the fibroblast growth factor receptor axis in cholangiocarcinoma
    Ang, Celina
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2015, 30 (07) : 1116 - 1122
  • [5] Tinengotinib in patients with advanced, fibroblast growth factor receptor (FGFR) inhibitor refractory/relapsed cholangiocarcinoma
    Javle, M.
    Fonkoua, L. A. Kankeu
    Mahipal, A.
    Liao, C-Y.
    Fountzilas, C.
    Li, D.
    Pelster, M. S.
    Goel, S.
    Peng, P.
    Sun, C.
    Wang, H.
    Hennessy, K.
    Fu, X.
    Neo, L.
    Shan, Y.
    Huang, P.
    Wu, D.
    Wu, F.
    Fan, J.
    Piha-Paul, S. A.
    ANNALS OF ONCOLOGY, 2023, 34 : S215 - S216
  • [6] Successful intrahepatic cholangiocarcinoma conversion surgery after administration of fibroblast growth factor receptor inhibitor
    Kaneko, Junichi
    Kiuchi, Ryota
    Takinami, Masaki
    Ohnishi, Ippei
    Ito, Jun
    Jindo, Osamu
    Nishino, Masafumi
    Takahashi, Yurimi
    Yamada, Takanori
    Sakaguchi, Takanori
    CLINICAL JOURNAL OF GASTROENTEROLOGY, 2024, 17 (05) : 936 - 942
  • [7] Fibroblast growth factor receptor 2 translocations in intrahepatic cholangiocarcinoma
    Graham, Rondell P.
    Fritcher, Emily G. Barr
    Pestova, Ekaterina
    Schulz, John
    Sitailo, Leonid A.
    Vasmatzis, George
    Murphy, Stephen J.
    McWilliams, Robert R.
    Hart, Steven N.
    Halling, Kevin C.
    Roberts, Lewis R.
    Gores, Gregory J.
    Couch, Fergus J.
    Zhang, Lizhi
    Borad, Mitesh J.
    Kipp, Benjamin R.
    HUMAN PATHOLOGY, 2014, 45 (08) : 1630 - 1638
  • [8] A Hippo and Fibroblast Growth Factor Receptor Autocrine Pathway in Cholangiocarcinoma
    Ilyas, Sumera I.
    Yamada, Daisaku
    Hirsova, Petra
    Bronk, Steven F.
    Werneburg, Nathan W.
    Krishnan, Anuradha
    Salim, Warda
    Zhang, Liang
    Trushina, Eugenia
    Truty, Mark J.
    Gores, Gregory J.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2016, 291 (15) : 8031 - 8047
  • [9] Cataracts Associated With Fibroblast Growth Factor Receptor Inhibitors for Cholangiocarcinoma
    Kassaye, Isabell
    Alyafaie, Adam
    Zhang, Karen
    Lifton, Jacob
    Gordan, John D.
    Kelley, Robin Kate
    Yung, Madeline
    JAMA OPHTHALMOLOGY, 2024, 142 (12) : 1109 - 1113
  • [10] A NEW ERA OF FIBROBLAST GROWTH FACTOR RECEPTOR INHIBITION IN CHOLANGIOCARCINOMA
    Lamarca, A.
    Moreno, V.
    Gambardella, V.
    Cervantes, A.
    ESMO OPEN, 2023, 8 (06)
12345